Curi RMB Capital’s Kyntra Bio KYNB Stock Holding History

Curi RMB Capital’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-400	Closed	-$213K	–	468
2016 Q1	$213K	Buy	+400	New	+$199K	0.01%	338

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Curi RMB Capital's KYNB Position: Q2 2016 in Review

Curi RMB Capital sold out of Kyntra Bio (KYNB) in Q2 2016, closing a stake of 400 shares — an estimated $213K sold.

Curi RMB Capital first reported a position in KYNB in Q1 2016 and held it in 1 quarter. The position peaked at $213K in Q1 2016. 146 funds tracked by Wall St. Rank hold KYNB as of Q2 2016.

Curi RMB Capital reported no remaining Kyntra Bio position as of Q2 2016 after selling out during the quarter.
Curi RMB Capital sold 400 Kyntra Bio shares in Q2 2016, an estimated $213K.
Curi RMB Capital first reported a position in Kyntra Bio in Q1 2016 and held it in 1 quarter.
Curi RMB Capital's Kyntra Bio position peaked at $213K in Q1 2016.
146 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2016.

Based on Curi RMB Capital's 13F filing for Q2 2016, filed 3 Aug 2016.